The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)
Official Title: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)
Study ID: NCT05466994
Brief Summary: To learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients scheduled for surgery.
Detailed Description: Primary Objective: •To assess the efficacy of SpellBound's AR-enabled scavenger hunt to reduce the rate of 90-day opioid use in pediatric cancer patients undergoing surgery compared to a control non-AR game in a randomized controlled trial. Secondary Objectives: To assess the effect of AR versus non-AR control technology in pediatric oncology patients, including: * Inpatient opioid use * Average daily inpatient pain score * Number of opioid requests during the hospital stay * Inpatient PedsQL (quality of life) questionnaire score * Ambulation/"out of bed" movement * Number days to discharge-ready status * Patient experience assessed by satisfaction scores on a questionnaire designed by MD Anderson Cancer Center Child Life team. * Outpatient opioid consumption reported at 30, 60, and 90 days * Outpatient pain scores reported at 30, 60, and 90 days * Outpatient PedsQL scores reported at 30, 60, and 90 days * Potential adverse events related to the use of AR (i.e., falls).
Minimum Age: 5 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
M D Anderson Cancer Center, Houston, Texas, United States
Texas Children's Hospital, Houston, Texas, United States
Name: Juan Cata, MD
Affiliation: M.D. Anderson Cancer Center
Role: PRINCIPAL_INVESTIGATOR